Articles tagged "Kidney transplantation"

2016 American Transplant Congress
The Clinical Differences Between First and Second Kidney Transplant in IgA Nephropathy: A Multicenter Retrospective Study.
C. Baek,¹ J. Lee,² J. Park,³ H. Kim,¹ Y. Kim,² W. Huh,³ J. Yang,⁴ D. Han,⁵ S.-K. Park.¹
¹Division of Nephrology, Asan Medical Center, Seoul, Republic of Korea; ²Department of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea; ³Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea; ⁴Transplantation Center, Seoul National University Hospital, Seoul, Republic of Korea; ⁵Department of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Background Recurrent IgA nephropathy (IgAN) after renal transplantation has been reported to range between 12% and 65%. However, few data are available on the second…
2016 American Transplant Congress
Prostate Cancer Characteristics and Outcome in Renal Transplant Recipients: Results from a Contemporary Monocentric Study.
C. Pettenati,¹ A.-S. Jannot,² V. Verkarre,³ S. Hurel,¹ H. Kreis,⁴ M. Housset,⁵ C. Legendre,⁴ A. Méjean,¹ M.-O. Timsit.¹
¹Department of Urology and Transplant surgery, Hôpital Européen Georges Pompidou, AP-HP, Université Paris Descartes, Paris, France; ²Department of Statistics, Computing and Public Health, Hôpital Européen Georges Pompidou, AP-HP, Université Paris Descartes, Paris, France; ³Department of Pathology, Hôpital Necker, AP-HP, Université Paris Descartes, Paris, France; ⁴Department of Nephrology and Transplantation, Hôpital Necker, AP-HP, Université Paris Descartes, Paris, France; ⁵Department of Onco-Radiotherapy, Hôpital Necker, AP-HP, Université Paris Descartes, Paris, France.
Objective To analyze prostate cancer characteristics in a contemporary monocentric renal transplant recipients (RTR) population and to compare oncological outcome after radical prostatectomy (RP) with…
2016 American Transplant Congress
Outcomes from De Novo Tacrolimus Weight-Based Dosing Compared to Conservative Dosing in Kidney Transplant Recipients.
B. Summers,² K. Szempruch,¹ M. Harris,² A. Quidley,¹ C. Haisch,¹ A. Maldonado.¹
¹Vidant Medical Center/East Carolina University, Greenville, NC; ²Duke University Hospital, Durham, NC.
Purpose: To compare de novo tacrolimus (TAC) weight based dosing (WDG) and conservative dosing (CDG) on incidence and duration of DGF in adult kidney transplant…
2016 American Transplant Congress
Effects of Immunosuppression and Sun Exposure on Immune Cell Populations in Skin and Blood of Kidney Transplant Recipients.
M. Burke,¹ L. Nahum,⁴ N. Isbel,¹ R. Carroll,³ H. Soyer,¹ R. Francis,¹ J. Bridge,¹ C. Staatz,² J. Wells.¹
¹Translational Research Institute, Brisbane, Australia; ²University of Queensland, Brisbane, Australia; ³Royal Adelaide Hospital, Adelaide, Australia; ⁴Ben Gurion University of the Negev, Beersheba, Israel.
BackgroundKidney transplant recipients (KTR) receiving sirolimus accrue fewer skin cancers than KTR receiving calcineurin inhibitor (CNI) based immunosuppression, potentially due to effects of sirolimus and…
2016 American Transplant Congress
Associations Between Deceased-Donor Urine MCP-1 and Kidney Transplant Outcomes.
S. Mansour,¹ J. Puthumana,¹ P. Reese,² I. Hall,¹ M. Doshi,³ F. Weng,⁴ B. Schröppel,⁵ H. Thiessen-Philbrook,^1,6 M. Bimali,¹ C. Parikh.¹
¹Nephrology, Yale University School of Medicine, New Haven, CT; ²Renal-Electrolyte and Hypertension, University of Pennsylvania, Philadelphia, PA; ³Wayne State University, Detroit, MI; ⁴Saint Barnabas Medical Center, Livingston, NJ; ⁵Nephrology, University Hospital, Ulm, Germany; ⁶Nephrology, Western University, London, ON, Canada.
Current assessments of deceased donor kidneys lack precision in predicting recipient graft function. Mouse models have demonstrated that monocyte chemoattractant protein-1 (MCP-1) has a pivotal…
2016 American Transplant Congress
Center-Level Variation in Association Between Early Hospital Readmission and Survival Following Kidney Transplantation.
S. Cramm, E. King, D. Segev.
Department of Surgery, Johns Hopkins, Baltimore.
Background: Early hospital readmission (EHR) following kidney transplantation (KT) is associated with inferior survival. However, incidence of EHR varies significantly across center following KT. Recent…
2016 American Transplant Congress
Tolerance Induction with Donor Bone Marrow Transplantation in Kidney Transplantation.
H. Park,¹ N. Lee,¹ S. Lee,¹ G. Choi,¹ C. Kwon,¹ S. Kim,¹ J.-W. Joh,¹ M. Kim,² Y. Kwon,² S.-K. Lee.¹
¹Department of Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea; ²Transplantation Research Center, Samsung Biomedical Research Institute, Seoul, Republic of Korea.
Tolerance induction is considered to be a final goal in the field of organ transplantation. We have performed simultaneous bone marrow and kidney transplantation in…
2016 American Transplant Congress
Belatacept Does Not Inhibit Plasmablast Formation Supported by Follicular T Helper Cells, but Favors the Development of Transitional Regulatory B Cells in Kidney Transplant Patients.
G. de Graav, D. Hesselink, M. Dieterich, R. Kraaijeveld, W. Weimar, C. Baan.
Internal Medicine, Section Transplantation and Nephrology, Erasmus University Medical Center, Rotterdam, South Holland, Netherlands.
Since the costimulatory inhibitor belatacept effectively blocks T-B cell interaction in animal transplant models, we studied the functional follicular T helper cells (TFH)-B cell interaction…
2016 American Transplant Congress
The Impact of Readmission following Kidney Transplantation: Is Readmission Becoming More Risky?
E. King, L. Kucirka, M. McAdams-DeMarco, A. Massie, D. Segev.
Surgery, Johns Hopkins University, School of Medicine, Baltimore, MD.
BACKGROUND: Following kidney transplantation, 31% of recipients experience early hospital readmission (EHR) and readmission is independently associated with increased risk of graft loss and mortality.…
2016 American Transplant Congress
Treatments Against Renin-Angiotensin-Aldosterone System Could Influence FGF23 and Klotho Levels in Renal Transplant Recipients.
S. Sezer,¹ E. Tutal,¹ Z. Bal,¹ M. Uyar,¹ M. Haberal.²
¹Nephrology, Baskent University Faculty of Medicine, Ankara, Turkey; ²General Surgery, Baskent University Faculty of Medicine, Ankara, Turkey.
Purpose: Angiotensin-converting enzyme inhibitor ( ACEI) and angiotensin II receptor blocker (ARB) are frequently used in post transplant hypertension. Recent trials reported that renin-angiotensin-aldosterone system…